학술논문
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma
Document Type
Article
Author
Liu, Yingqiang; Zhan, Zhengsheng; Kang, Zhuang; Li, Mengyuan; Lv, Yongcong; Li, Shenglan; Tong, Linjiang; Feng, Fang; Li, Yan; Zhang, Mengge; Xue, Yaping; Chen, Yi; Zhang, Tao; Song, Peiran; Su, Yi; Shen, Yanyan; Sun, Yiming; Yang, Xinying; Yao, Shanyan; Yang, Hanyu; Wang, Caixia; Geng, Meiyu; Li, Wenbin; Duan, Wenhu; Xie, Hua; Ding, Jian
Source
In Acta Pharmaceutica Sinica B December 2023 13(12):4748-4764
Subject
Language
ISSN
2211-3835